Sanofi (XBUL:SNW) Machinery, Furniture, Equipment : лв23,386 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sanofi Machinery, Furniture, Equipment?

Sanofi's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2024 was лв23,386 Mil.

Sanofi's quarterly Machinery, Furniture, Equipment declined from Dec. 2023 (лв25,434 Mil) to Jun. 2024 (лв0 Mil) but then increased from Jun. 2024 (лв0 Mil) to Dec. 2024 (лв23,386 Mil).

Sanofi's annual Machinery, Furniture, Equipment increased from Dec. 2022 (лв24,616 Mil) to Dec. 2023 (лв25,434 Mil) but then declined from Dec. 2023 (лв25,434 Mil) to Dec. 2024 (лв23,386 Mil).

Sanofi Machinery, Furniture, Equipment Historical Data

The historical data trend for Sanofi's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Machinery, Furniture, Equipment Chart

Sanofi Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

30,258.15

28,104.18

24,616.09

25,433.80

23,385.69

Sanofi Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															24,616.09	-	25,433.80	-	23,385.69

Sanofi Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Sanofi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (XBUL:SNW) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:USA SNY N:Mexico 1SAN:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SANO:Austria

Address

46, Avenue de la Great Army, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Sanofi Headlines

No Headlines